insights_auto
Outlook: 66.7% bullish·0.0% bearish
Go to analysischevron_right
ACRS:NASDAQ
Aclaris Therapeutics Inc
$3.97
arrow_downward
-0.50%(-0.020) 1D
$4.03
arrow_upward
+1.51% (+0.060)bedtimeAfter hours
Closed: Oct 30, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 7 analysts giving stock ratings to ACRS in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ACRS in the last 3 months.
Highest
Current $3.97
$16.00 (+303.02%)
Average
$12.00 (+202.27%)
Lowest
$9.00 (+126.70%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Edward Nash Canaccord Genuity | Buy | Reiterated | $13.00 | +227.5% | 10/30/2026 |
Seamus Fernandez Guggenheim | Buy | Reiterated | $12.00 | +202.3% | 10/28/2026 |
Adam Vogel Craig-Hallum | Buy | Maintained | $9.00 | +126.7% | 10/28/2026 |
Unknown Analyst Oppenheimer | Buy | Reiterated | $10.00 | +151.9% | 10/28/2026 |
Ram Selvaraju H.C. Wainwright | Buy | Reiterated | $16.00 | +303% | 10/28/2026 |
Biren Amin Piper Sandler | Buy | Maintained | $11.00 | +177.1% | 10/19/2026 |
Kate Dellorusso LifeSci Capital | Buy | Maintained | $13.00 | +227.5% | 10/01/2026 |
Martin Fan Wedbush | Buy | Maintained | $10.00 | +151.9% | 05/08/2026 |
Jeff Jones Oppenheimer | Buy | Reiterated | $10.00 | +151.9% | 05/08/2026 |
Alex Thompson CFA Stifel Nicolaus | Hold | Maintained | $4.00 | +0.8% | 05/08/2026 |
Unknown Analyst Goldman Sachs | Buy | Maintained | $10.00 | +151.9% | 04/16/2026 |